Tumour Markers for Prediction of Survival and Monitoring of Remission in Small Cell Lung Cancer

Lung Cancer - Netherlands
doi 10.1016/0169-5002(94)90835-4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Disease Monitoring by the Tumour Markers Cyfra 21.1 and TPA in Patients With Non-Small Cell Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
1995English

Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2020English

Different Patterns of Stromal and Cancer Cell Thymidine Phosphorylase Reactivity in Non-Small-Cell Lung Cancer: Impact on Tumour Neoangiogenesis and Survival

British Journal of Cancer
Cancer ResearchOncology
1998English

Nomograms Predict Overall Survival for Patients With Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Effects of Biological Markers on Overall Survival in Surgically Treated Patients With Non Small Cell Lung Cancer

Vojnosanitetski Pregled
MedicinePharmacology
2020English

P2.16-08 Influence of Tumour Location and Histological Sub-Type of Non-Small Cell Lung Cancer on Patient Survival

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immune Markers in Non-Small Cell Lung Cancer: What Else Beyond Pd-L1 and Tumour Mutational Burden Is There?

Biomedical Journal of Scientific & Technical Research
2019English

Interleukin-10-Regulated Tumour Tolerance in Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2017English

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy